AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects - Contacts and Locations

Home

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

This study is ongoing, but not recruiting participants.

Study NCT00443326. Last updated on September 18, 2008. Information provided by Amgen

Please refer to this study by its ClinicalTrials.gov identifier: NCT00443326

Sponsors and Collaborators

Amgen

Investigators


Study Director:	MD	Amgen